Protara Therapeutics, Inc.TARANASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
11.43%
↑ 165% above average
Average (39q)
-17.67%
Historical baseline
Range
High:94.66%
Low:-524.14%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 11.43% |
| Q2 2025 | -20.69% |
| Q1 2025 | 39.58% |
| Q4 2024 | 4.00% |
| Q3 2024 | -11.11% |
| Q2 2024 | 53.61% |
| Q1 2024 | -7.78% |
| Q4 2023 | -3.45% |
| Q3 2023 | 13.00% |
| Q2 2023 | -35.14% |
| Q1 2023 | 78.55% |
| Q4 2022 | -422.73% |
| Q3 2022 | 9.59% |
| Q2 2022 | 23.16% |
| Q1 2022 | -4.40% |
| Q4 2021 | 5.21% |
| Q3 2021 | 15.79% |
| Q2 2021 | 5.00% |
| Q1 2021 | -51.90% |
| Q4 2020 | 37.30% |
| Q3 2020 | -3.28% |
| Q2 2020 | 32.60% |
| Q1 2020 | -524.14% |
| Q4 2019 | 68.48% |
| Q3 2019 | -64.29% |
| Q2 2019 | 3.45% |
| Q1 2019 | -7.41% |
| Q4 2018 | 94.66% |
| Q3 2018 | 8.75% |
| Q2 2018 | 19.75% |
| Q1 2018 | -9.60% |
| Q4 2017 | 54.93% |
| Q3 2017 | -114.41% |
| Q2 2017 | 15.70% |
| Q1 2017 | 8.83% |
| Q4 2016 | 2.08% |
| Q3 2016 | 10.11% |
| Q2 2016 | -20.71% |
| Q1 2016 | -3.36% |
| Q4 2015 | -17.84% |